AI Summary
- Argues that hypnotic discontinuation alone does not equate to successful deprescribing; success requires sustained symptom control and reduced medication burden.
- Calls for standardised outcome measures beyond cessation, including relapse rates, functional status, adverse events, and patient satisfaction.
- Recommends patient centred tapering strategies, multidisciplinary support, and policy facilitation to ensure durable, safe deprescribing in clinical practice.
Psychiatry Clin Neurosci. 2026 Sep 1. doi: 10.1111/pcn.70130. Online ahead of print.
ABSTRACT
This article is a response to ‘Hypnotic discontinuation is not synonymous with successful deprescribing: A Taiwan perspective’.
PMID:42680686 | DOI:10.1111/pcn.70130
Share Evidence Blueprint
Save to Google Notes
Search Google Scholar
Save as PDF
⭐ My Revision List
